Ganjapreneur.com

Florida’s Trulieve Among Six Companies Tabbed to Produce Low-THC Oil in Georgia

Trulieve GA Inc. and Biomedical Sciences LLC were awarded the two Class 1 licenses to produce low-THC medical cannabis oil for Georgia’s medical cannabis program.

Full story continued below.

Advertisement

Advertise Here

Trulieve GA Inc. and Biomedical Sciences LLC were awarded the two Class 1 licenses to produce low-THC medical cannabis oil for Georgia’s medical cannabis program, while FFD GA Holdings, TheraTrue Georgia, Natures GA, and Treevana Remedy were tabbed for the Class 2 licenses, Capitol Beat News Service reports.

The Class 1 licenses allow licensees to grow cannabis up to 100,000 square feet of growing space, while Class 2 licensees are allowed to cultivate in up to 50,000 square feet. The licenses were created under a 2019 law despite the state legalizing medical cannabis oil containing up to 5% THC for patient use in 2015.

Trulieve is the largest cannabis company in Florida and CEO Kim Rivers said the company feels “well-positioned to approach the Georgia market with the same commitment to quality products, patient access, and positive customer experience” as in the firm’s home state.

The oil will be sold at licensed dispensaries or specially licensed pharmacies to patients with one or a combination of 17 medical conditions.

Danielle Benson, vice-chair of the Georgia Access to Medical Cannabis Commissionwhich reviewed the industry applications and chose the winnerssaid the announcement “is an indication that help is on the way for Georgians.”

“Because of the dedication and hard work of the commission, we have been able to stay focused on getting the work done while always keeping patients’ needs as a top priority.” Benson via the Capitol Beat News Service

The law allowed 70 companies to apply. The commission has estimated that it will take six to eight months for the companies to get operational and make the oil available to the state’s registered patients.

Under current law, Georgians enrolled in the medical cannabis program are allowed to possess low-THC oil but there is currently no state-approved mechanism for obtaining the products, forcing most patients to run afoul of federal law by crossing state lines with the oils.

[mashshare]

Get daily news insights in your inbox. Subscribe

End


Exit mobile version